# Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

> **NCT00020735** · PHASE2 · COMPLETED · sponsor: **Joel Nelson, MD** · enrollment: 45 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** toremifene
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy

## Key facts

- **NCT ID:** NCT00020735
- **Lead sponsor:** Joel Nelson, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2005-01
- **Final completion:** 2009-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2015-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020735, "Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00020735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*